- Previous Close
0.1350 - Open
0.1350 - Bid 0.1350 x --
- Ask 0.1400 x --
- Day's Range
0.1350 - 0.1350 - 52 Week Range
0.1250 - 0.5800 - Volume
21,500 - Avg. Volume
47,325 - Market Cap (intraday)
7.281M - Beta (5Y Monthly) 0.31
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0600 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Cytophage Technologies Ltd., a biotechnology company, engages in the research, development, and commercialization bacteriophage therapies to treat bacterial infections affecting human health, animal health, and food security in Canada. It develops poultry health products under the AviPhage name; food safety products under the PhageFend name; bovine mastitis products under the BoviPhage name; and water-soluble solution for livestock producers under the FarmPhage name. The company is headquartered in Winnipeg, Canada.
cytophage.comRecent News: CYTO.V
View MorePerformance Overview: CYTO.V
Trailing total returns as of 4/9/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CYTO.V
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CYTO.V
View MoreValuation Measures
Market Cap
7.28M
Enterprise Value
6.52M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
1.74
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-7.91M
Diluted EPS (ttm)
-0.0600
Balance Sheet and Cash Flow
Total Cash (mrq)
2.36M
Total Debt/Equity (mrq)
38.06%
Levered Free Cash Flow (ttm)
--